Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22.2K Sell
15,336
-7,991
-34% -$10.6K ﹤0.01% 1449
2025
Q4
$31.7K Buy
+23,327
New +$40.2K ﹤0.01% 1399
2025
Q1
$28.4K Buy
+10,110
New +$35.8K ﹤0.01% 1328
2019
Q2
Sell
-111
Closed -$2 3156
2019
Q1
$2 Buy
+111
New +$2.46K ﹤0.01% 2850
2017
Q1
Sell
-240
Closed -$5K 2737
2016
Q4
$5K Buy
+240
New +$6.16K ﹤0.01% 2240
2016
Q1
Sell
-180
Closed -$5K 2711
2015
Q4
$5K Hold
180
﹤0.01% 2273
2015
Q3
$4K Hold
180
﹤0.01% 2372
2015
Q2
$4K Buy
+180
New +$4.54K ﹤0.01% 2293

Other funds holding SABR

Glenmede Trust's SABR Position: Q1 2026 in Review

Glenmede Trust reduced its Sabre (SABR) stake by 34% in Q1 2026, selling an estimated $10.6K and leaving 15,336 shares worth $22.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1449.

Glenmede Trust first reported a position in SABR in Q2 2015 and has held it in 8 quarters since. The position peaked at $31.7K in Q4 2025. 242 funds tracked by Wall St. Rank hold SABR as of Q1 2026.

  • Glenmede Trust held 15,336 shares of Sabre worth $22.2K as of Q1 2026.
  • Glenmede Trust sold 7,991 Sabre shares in Q1 2026, an estimated $10.6K.
  • Sabre made up ﹤0.01% of Glenmede Trust's portfolio in Q1 2026, its #1449 holding.
  • Glenmede Trust first reported a position in Sabre in Q2 2015 and has held it in 8 quarters since.
  • Glenmede Trust's Sabre position peaked at $31.7K in Q4 2025.
  • 242 funds tracked by Wall St. Rank held Sabre as of Q1 2026.

Based on Glenmede Trust's 13F filing for Q1 2026, filed 26 May 2026.